{
  "nctId": "NCT01943409",
  "briefTitle": "Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils",
  "officialTitle": "Parenteral Nutrition in Hospitalized Patients: Comparison of Two Commercially Available Lipid Emulsions",
  "protocolDocument": {
    "nctId": "NCT01943409",
    "filename": "Prot_SAP_001.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2014-03-13",
    "uploadDate": "2022-11-01T09:41",
    "size": 455601,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT01943409/document/Prot_SAP_001.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 303,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2013-07",
    "completionDate": "2019-12",
    "primaryCompletionDate": "2019-12",
    "firstSubmitDate": "2013-07-17",
    "firstPostDate": "2013-09-17"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients 18 years or older\n\n  * Patients with PN during their hospitalization\n  * Patients hospitalized in medical, surgical or ICU wards\n  * Signed informed consent either from the patient, their legally authorized representative or a direct family member\n\nExclusion Criteria:\n\n* â€¢ Patients without PN during their hospitalization",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Prealbumin",
        "description": "prealbumin is an hepatic protein that is used in the diagnosis of malnutrition. It has a short half-life so any changes in nutritional status can rapidly be represented by prealbumin levels.",
        "timeFrame": "at day 10"
      }
    ],
    "secondary": [
      {
        "measure": "Length of Stay",
        "description": "Length of stay in the hospital and ICU will be recorded for 1 year",
        "timeFrame": "participants will be followed for the duration of hospital stay up to one year"
      },
      {
        "measure": "Mortality",
        "description": "We will follow the patients from the day of admission until the day of discharge and record the mortality for 1 year",
        "timeFrame": "participantes will be followed for the duration of hospital stay for up to 1 year"
      },
      {
        "measure": "Infections",
        "description": "we will record the infections the patients develop during PN until one week after PN for 1 year",
        "timeFrame": "until one week post-PN up to 1 year"
      },
      {
        "measure": "Change in Hand-grip Strength",
        "description": "We will measure hand grip strength at baseline (day0) and at day 10 of PN. This is a test that measures the strength of the hand and forearm muscles and is often used as a general test of strength",
        "timeFrame": "at baseline (day 0) and day 10 of PN"
      },
      {
        "measure": "Change in Mid-arm Circumference",
        "description": "This is a rough indicator of body fat",
        "timeFrame": "at baseline (day0) and day 10"
      },
      {
        "measure": "Subjective Global Assessment (SGA): Number Who Improved",
        "description": "is a bedside method that assesses the risk of malnutrition and identifies which patient will benefit best from nutrition support",
        "timeFrame": "at baseline (day 0) and day 10"
      },
      {
        "measure": "Change in High Sensitivity C-reactive Protein (Hs-CRP)",
        "description": "hs-CRP is a marker of inflammation, we will measure this parameter at baseline and after 10 days of PN",
        "timeFrame": "Baseline (day 0) and day 10"
      },
      {
        "measure": "Red Blood Cell Fatty Acid Composition: Linoleic",
        "description": "Red blood cell fatty acid composition, particularly the essential fatty acids (linoleic acid and alpha-linolenic acid) will be measured to assess presence/absence of essential fatty acid deficiency",
        "timeFrame": "day 10"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 8,
      "otherCount": 0,
      "totalCount": 9
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 79,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:31:00.444Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}